K. Yui

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K Yui, K. Yui, Kunio Yui
Publication record
91 papers · 1,275 citations · H-index 21

PAPERS

DHA/Arachidonic Acid Ratio Contribute to Lipid Peroxidation in Social Behaviors of Individuals with Autism Spectrum Disorder
20230 citationsauthor #1
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
202224 citationsauthor #1
Lipid Peroxidation With Implication of Organic Pollution in Autistic Behaviors
20214 citationsauthor #1
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
20216 citationsauthor #2
The role of lipid peroxidation in individuals with autism spectrum disorders
20200 citationsauthor #1
Contribution of Transferrin and Ceruloplasmin Neurotransmission and Oxidant/Antioxidant Status to the Effects of Everolimus: A Case Series
20202 citationsauthor #1
The role of lipid peroxidation in individuals with autism spectrum disorders
20209 citationsauthor #1
Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
20199 citationsauthor #1
The Association between Epileptiform Activity and Autistic Symptoms in Three Cases with Tuberous Sclerosis
20190 citationsauthor #1
The Large Effect Size of Urinary Total Antioxidant Capacity in Behavioral Symptoms of Young Autistic Individuals: Comparion with Omega-3 Fatty Acid and Superoxide Dismutase in Plasma
20180 citationsauthor #1
The role of imbalance between urinary hexanoyl-lysine and total antioxidant capacity levels and its relation to plasma superoxide dismutase levels in autism spectrum disorder
20180 citationsauthor #1
Comparing Urinary Effect Size Related to Behavioral Symptoms between Total Antioxidant Capacity and Hexanoyl-lysine in Individuals with Autism Spectrum Disorders
20181 citationsauthor #1
The role of antioxidant proteins in improvement of autism core symptoms in two patients with tuberous sclerosis treated with mTOR inhibitor everolimus
20181 citationsauthor #1
Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder
201715 citationsauthor #1
Imbalance between Urinary Hexanoyl-lysine and Total Antioxidant Capacity Levels and Plasma Superoxide Dismutase Levels in Individuals with Autism Spectrum Disorder
20171 citationsauthor #1
Therapeutic Potential of Everolimus on Core Autism Symptoms andIncreasing Serum Ceruloplasmin and Transferrin Levels in a PubescentBoy with Tuberous Sclerosis
20171 citationsauthor #1
Psychological Discrepancies found in Children and Adolescents
20170 citationsauthor #1
Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder
201721 citationsauthor #1
Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders.
201672 citationsauthor #1
Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator.
20163 citationsauthor #1
Editorial: New Therapeutic Targets for Autism Spectrum Disorders.
20163 citationsauthor #1
Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disorders.
201619 citationsauthor #1
Psycho-Cognitive Intervention for ASD from Cross-Species Behavioral Analyses of Infants, Chicks and Common Marmosets.
20167 citationsauthor #5
Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
201634 citationsauthor #1
Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders.
201534 citationsauthor #1
Down-regulation of Signaling Mediator in Related to Increased Ratio of Docosahexaenoic Acid/Arachidonic Acid in Individuals with Autism Spectrum Disorders
20151 citationsauthor #1
Mitochondrial Dysfunction and Its Relation to Translocator Protein, Oxidative Stress, mTOR Signaling, and Synaptic Protein.
20150 citationsauthor #1
Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders
201599 citationsauthor #1
EDITORIAL New Targets of Medical Treatment in Psychiatric Disorders
20150 citationsauthor #1
Video Game Play May Attenuate Cortisol Response To Psychosocial Stress In Individuals With Autism Spectrum Disorders
20141 citationsauthor #1
Pharmacological Treatments, Related Clinical Characteristics and Brain Function in Adolescent Depression
20130 citationsauthor #1
Future Target of Treatment for Social Impairment of Autism Spectrum
20131 citationsauthor #1
Impaired Social Interaction in Autism Spectrum Disorders
20130 citationsauthor #1
Current Pharmacologic Treatments in Impaired Social Interaction in Autism Spectrum Disorders
20132 citationsauthor #1
Plasma Cortisol Response to Asked Questions on Recent Events during Videogame Play in Individuals with Autism Spectrum Disorders
20136 citationsauthor #1
Neurobiological Basis and Pharmacologic Treatment of Social Impairment in Autism Spectrum Disorders
20121 citationsauthor #1
Editorial [The Role of Arachidonic Acid in the Neuronal Development in Relation to Psychiatric Disorders]
20120 citationsauthor #1
Efficacy of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid against Restricted Repetitive Behaviors in Individuals with AutismSpectrum Disorders: A Placebo-Controlled Trial
20123 citationsauthor #1
[Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].
20124 citationsauthor #1
Effects of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid on Social Impairment in Individuals with Autism Spectrum Disorders
20120 citationsauthor #1
[Development and neural basis of social behavior].
20120 citationsauthor #11
Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled, Randomized Trial
201294 citationsauthor #1
Effects of constant daylight exposure during early development on marmoset psychosocial behavior.
201122 citationsauthor #9
Neural basis of active cognition ubiquitous in human and other animals
20110 citationsauthor #10
[Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders].
20118 citationsauthor #1
Non-contact behavioral/physiological measuring system for quantitativepsychiatric diagnosis - from animal model to human social disorder
20100 citationsauthor #2
[Effects of arachidonic acids on social behavior in patients with autism spectrum disorders].
20090 citationsauthor #1
[Cerebral physiopathology and treatment of Asperger disorder].
20080 citationsauthor #1
Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex.
200843 citationsauthor #4
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
200853 citationsauthor #6
[Formation of premorbid stress vulnerability in schizophrenia].
20071 citationsauthor #1
WS-1 Impact of Anxiety and Depressive Mood on the Development of Eating and Panic Disorders(ISPOG2007)
20070 citationsauthor #1
Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia
20060 citationsauthor #1
[Future direction of psychiatry for women].
20040 citationsauthor #1
The Role of Noradrenergic and Dopaminergic Hyperactivity in the Development of Spontaneous Recurrence of Methamphetamine Psychosis and Susceptibility to Episode Recurrence
200425 citationsauthor #1
[Stress sensitization induced by stressor and methamphetamine].
20041 citationsauthor #1
Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex.
200432 citationsauthor #4
Susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
20037 citationsauthor #1
Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
200242 citationsauthor #4
Factors for Susceptibility to Episode Recurrence in Spontaneous Recurrence of Methamphetamine Psychosis
200226 citationsauthor #1
Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia.
200236 citationsauthor #1
The relation between plasma prolactin and homovanillic acid (HVA) concentrations and classification of clinical course in schizophrenia
20020 citationsauthor #1
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
200131 citationsauthor #1
Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.
2001161 citationsauthor #3
Susceptibility to Subsequent Episodes in Spontaneous Recurrence of Methamphetamine Psychosis
200013 citationsauthor #1
Preface: Recent advances of neurobiological basis of stimulant‐induced sensitization
20000 citationsauthor #1
[Evolution and update of detoxification techniques for opiate addicts].
20000 citationsauthor #1
Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia
200095 citationsauthor #1
Increased sensitivity to stress associated with noradrenergic hyperactivity, involving dopaminergic hyperactivity in spontaneous recurrences in methamphetamine psychosis
20003 citationsauthor #1
Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
200028 citationsauthor #1
Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
200029 citationsauthor #1
Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis
199915 citationsauthor #1
Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change
199916 citationsauthor #1
[Clinical efficacy of olanzapine].
19990 citationsauthor #1
Monoamine Metabolites Analysis in Blood and the Relation to Flashback Occurrence in Methamphetamine Psychosis
19980 citationsauthor #2
Factors affecting the development of spontaneous recurrence of methamphetamine psychosis
19983 citationsauthor #1
Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function.
199736 citationsauthor #1
Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis.
19975 citationsauthor #1
Precipitating factors in spontaneous recurrence of methamphetamine psychosis
199724 citationsauthor #1
Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis.
19977 citationsauthor #1
Noradrenergic hyperactivity and spontaneous recurrence of methamphetamine psychosis
19960 citationsauthor #1
Effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine on behavioral sensitization and conditioning.
19964 citationsauthor #1
Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks.
19969 citationsauthor #1
Infection with GB virus C in female prisoners who were drug abusers in Japan
19960 citationsauthor #1
Monoamine Neurotransmitter Function and Spontaneous Recurrence of Methamphetamine Psychosis
19965 citationsauthor #1
Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats.
19965 citationsauthor #1
Methamphetamine plus scopolamine potentiates behavioral sensitization and conditioning.
19956 citationsauthor #1
Comparison of Behavioural Effects of Repeated Treatment with Methamphetamine plus Scopolamine and Methamphetamine Alone on Behavioural Sensitization and Conditioned Response
19952 citationsauthor #1
Spontaneous recurrence of methamphetamine psychosis: process and monoamine neurotransmitter function.
19951 citationsauthor #1
Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
19942 citationsauthor #1
[Cholinergic modulation on stereotyped behavior and behavioral hypersensitivity (reverse tolerance) in rats].
19913 citationsauthor #1

TIMELINE

1991 3 citations

1994 2 citations

1995 9 citations

1996 23 citations

1997 72 citations

1998 3 citations

1999 31 citations

2000 168 citations

2001 192 citations

2002 104 citations

2003 7 citations

2004 58 citations

2006 0 citations

2007 1 citations

2008 96 citations

2009 0 citations

2010 0 citations

2011 30 citations

2012 102 citations

2013 9 citations

2014 1 citations

2015 134 citations

2016 138 citations

2017 38 citations

2018 2 citations

2019 9 citations

2020 11 citations

2021 10 citations

2022 24 citations

2023 0 citations

K. Yui

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT